azimilide has been researched along with Cardiovascular Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bharucha, DB; Dorian, P; Kowey, PR; Mahaffey, KW; Robinson, VM | 1 |
1 trial(s) available for azimilide and Cardiovascular Diseases
Article | Year |
---|---|
Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial.
Topics: Aged; Anti-Arrhythmia Agents; Cardiovascular Diseases; Death, Sudden, Cardiac; Defibrillators, Implantable; Double-Blind Method; Early Termination of Clinical Trials; Electric Countershock; Emergency Service, Hospital; Female; Heart Failure; Hospitalization; Humans; Hydantoins; Male; Middle Aged; Odds Ratio; Piperazines; Proportional Hazards Models; Stroke Volume; Tachycardia, Ventricular; Ventricular Fibrillation | 2017 |